# Maher Masoud

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/maher-masoud
Canonical HTML page: https://gethealthbrief.com/entity/maher-masoud

## Recent coverage (1 stories)

### MaxCyte Faces 2026 Headwinds Amid Cell Therapy Program Rationalization
2026-03-25 00:44:22 · Sentiment: Positive · Impact: 7/10 · Sources: 2

MaxCyte reported a 15% revenue decline for 2025, driven by the loss of six clinical programs and reduced spending from its largest customer. Despite these headwinds, the company expanded its installed base to 857 units and significantly improved gross margins through aggressive cost-cutting measures.
Full story: https://gethealthbrief.com/story/maxcyte-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.